Tag: Dan Barber

Aquestive AQST-109 Epinephrine Film

Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...

Response confirms approach and supports the characterization of their novel drug platform.
Aquestive's AQST-109

Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...

The company announced topline results from their EPIPHAST II study.
Aquestive AQST-109 Epinephrine Film

Aquestive Reports Positive Results from Sublingual Epinephrine Clinical Trial

Phase 2 study continues to show AQST-109 is safe and well tolerated.
Aquestive's Subingual Epinephrine

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company updates the public on status of their candidate drug administered under the tongue.